Objective: To validate an updated version (Version 2) of a single-nucleotide polymorphism (SNP)-based noninvasive prenatal test (NIPT) and to determine the likelihood of success when testing for fetal aneuploidies following a redraw.
Methods: Version 2 was analytically validated using 587 plasma samples with known genotype (184 trisomy 21, 37 trisomy 18, 15 trisomy 13, 9 monosomy X, 4 triploidy and 338 euploid). Sensitivity, specificity and no-call rate were calculated, and a fetal-fraction adjustment was applied to enable projection of these values in a commercial distribution. Likelihood of success of a second blood draw was computed based on fetal fraction and maternal weight from the first draw.
Results: Validation of this methodology yielded high sensitivities (≥99.4%) and specificities (100%) for all conditions tested with an observed no-call rate of 2.3%. The no-call threshold for sample calling was reduced to 2.8% fetal fraction. The redraw success rate was driven by higher initial fetal fractions and lower maternal weights, with the fetal fraction being the more significant variable.
Conclusions: The enhanced version of this SNP-based NIPT method showed a reduced no-call rate and a reduced fetal-fraction threshold for sample calling in comparison to the earlier version, while maintaining high sensitivity and specificity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000442931 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cell-free DNA screening for common autosomal trisomies using rolling-circle replication in twin pregnancies.
Prenat Diagn
July 2024
Department of Obstetrics and Gynecology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
Article Synopsis
- The study aimed to assess the effectiveness of RCR-cfDNA testing for detecting common autosomal trisomies in twin pregnancies compared to singleton pregnancies.
- It involved a multicenter analysis of 862 twin pregnancies, focusing on the rate of no-call results and the accuracy of detecting trisomy 21, 18, and 13.
- Results showed that the RCR-cfDNA test achieved 100% accuracy for detecting all trisomies with a low no-call rate in twin pregnancies, indicating its reliability as a first-tier screening option.
Performance of cell-free DNA testing for common fetal trisomies in triplet pregnancies.
Prenat Diagn
May 2024
Division of Obstetrics and Gynecology, "Antoine Béclère" Hospital, Paris Saclay University, APHP, Clamart, France.
Article Synopsis
- The study investigates the effectiveness of cell-free DNA (cfDNA) testing for detecting fetal aneuploidies in women with triplet pregnancies, as current data is limited compared to singleton pregnancies.
- The research involved a retrospective analysis of 255 women who underwent cfDNA testing between 2017 and 2020, focusing primarily on trisomy 21 (T21) and secondarily on trisomy 18 (T18) and trisomy 13 (T13).
- Results indicated that cfDNA testing can serve as a primary screening tool for major fetal aneuploidies in triplet pregnancies, highlighting the importance of informed patient consent before proceeding with the test.
Cell-Free Fetal DNA Screening Analysis in Korean Pregnant Women: Six Years of Experience and a Retrospective Study of 9327 Patients Analyzed from 2017 to 2022.
J Pers Med
October 2023
Center for Genome Diagnostics, CHA Biotech Inc., Seoul 06125, Republic of Korea.
Cell-free DNA (cfDNA) screening for normal fetal aneuploidy has been widely adopted worldwide due to its convenience, non-invasiveness, and high positive predictive rate. We retrospectively evaluated 9327 Korean women with single pregnancies who underwent a non-invasive prenatal test (NIPT) to investigate how various factors such as maternal weight, age, and the method of conception affect the fetal fraction (FF). The average FF was 9.
View Article and Find Full Text PDFAnalysis of retest reliability for pregnant women undergoing cfDNA testing with a no-call result.
Mol Biol Rep
September 2023
Medical Genetic Diagnosis and Therapy Center, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Key Laboratory for Prenatal Diagnosis and Birth Defect, Fujian Medical University, Fuzhou, China.
Background: Determining the reasons for unreportable or no-call cell-free DNA (cfDNA) test results has been an ongoing issue, and a consensus on subsequent management is still lacking. This study aimed to explore potential factors related to no-call cfDNA test results and to discuss whether retest results are reliable.
Methods And Results: This was a retrospective study of women with singleton pregnancies undergoing cfDNA testing in 2021.
Clinical Experience with Genome-Wide Noninvasive Prenatal Screening in a Large Cohort of Twin Pregnancies.
Genes (Basel)
April 2023
AMES, Centro Polidiagnostico Strumentale, 80013 Naples, Italy.
Non-invasive prenatal screening (NIPS) in twin gestations has been shown to have high detection rates and low false-positive rates for trisomy 21, as seen in singleton pregnancies, although there have been few large cohort twin studies, genome-wide studies in particular, to date. In this study, we looked at the performance of genome-wide NIPT in a large cohort consisting of 1244 twin pregnancy samples collected over a two-year period in a single laboratory in Italy. All samples underwent an NIPS for common trisomies, with 61.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!